Genetic and epigenetic changes in human epithelial cells immortalized by telomerase.

[1]  Robert A. Weinberg,et al.  Creation of human tumour cells with defined genetic elements , 1999, Nature.

[2]  G. Peters,et al.  Role of the alternative INK4A proteins in human keratinocyte senescence: evidence for the specific inactivation of p16INK4A upon immortalization. , 1999, Cancer research.

[3]  R. Fåhraeus,et al.  The p16INK4a tumour suppressor protein inhibits αvβ3 integrin‐mediated cell spreading on vitronectin by blocking PKC‐dependent localization of αvβ3 to focal contacts , 1999 .

[4]  J. Sedivy,et al.  Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. , 1999, Cancer research.

[5]  V. Dulic,et al.  Differential Roles for Cyclin-Dependent Kinase Inhibitors p21 and p16 in the Mechanisms of Senescence and Differentiation in Human Fibroblasts , 1999, Molecular and Cellular Biology.

[6]  K. Anderson,et al.  Restoration of p16INK4A protein induces myogenic differentiation in RD rhabdomyosarcoma cells , 1999, British Journal of Cancer.

[7]  R. Fåhraeus,et al.  The p16(INK4a) tumour suppressor protein inhibits alphavbeta3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of alphavbeta3 to focal contacts. , 1999, The EMBO journal.

[8]  M. White,et al.  Absence of cancer–associated changes in human fibroblasts immortalized with telomerase , 1999, Nature Genetics.

[9]  Xu-Rong Jiang,et al.  Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype , 1999, Nature Genetics.

[10]  T. Kiyono,et al.  Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells , 1998, Nature.

[11]  S. Lowe,et al.  Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. , 1998, Genes & development.

[12]  C. Sherr,et al.  Tumor surveillance via the ARF-p53 pathway. , 1998, Genes & development.

[13]  Karen H. Vousden,et al.  p14ARF links the tumour suppressors RB and p53 , 1998, Nature.

[14]  Kevin Ryan,et al.  The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2 , 1998, The EMBO journal.

[15]  F. Zindy,et al.  Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Seth,et al.  Up-regulation of p27Kip1, p21WAF1/Cip1 and p16Ink4a is associated with, but not sufficient for, induction of squamous differentiation. , 1998, Journal of cell science.

[17]  Ken Chen,et al.  The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53 , 1998, Cell.

[18]  Yue Xiong,et al.  ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways , 1998, Cell.

[19]  P. Jones,et al.  The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. , 1998, Cancer research.

[20]  G. Adami,et al.  Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts , 1998, Oncogene.

[21]  D. Sidransky,et al.  Role of the p16 tumor suppressor gene in cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  C. Der,et al.  Mas Oncogene Signaling and Transformation Require the Small GTP-Binding Protein Rac , 1998, Molecular and Cellular Biology.

[23]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[24]  M. Newton,et al.  Overcoming cellular senescence in human cancer pathogenesis. , 1998, Genes & development.

[25]  C. D. Edwards,et al.  p16INK4A Participates in a G1 Arrest Checkpoint in Response to DNA Damage , 1998, Molecular and Cellular Biology.

[26]  J. Decaprio,et al.  p16INK4A promotes differentiation and inhibits apoptosis of JKB acute lymphoblastic leukemia cells. , 1997, Blood.

[27]  D. Wong,et al.  p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. , 1997, Cancer research.

[28]  R. Haw,et al.  Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes , 1997, Oncogene.

[29]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[30]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[31]  J. Decaprio,et al.  Promotes Differentiation and Inhibits Apoptosis of JKB Acute Lymphoblastic Leukemia Cells , 1997 .

[32]  G. Hannon,et al.  Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Reddel,et al.  Association of extended in vitro proliferative potential with loss of p16INK4 expression. , 1996, Oncogene.

[34]  C. Sommer,et al.  Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. , 1996, Oncogene.

[35]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Stanley,et al.  Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. , 1996, Oncogene.

[37]  C. Reznikoff,et al.  Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. , 1996, Cancer research.

[38]  L. Chin,et al.  Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.

[39]  G. Peters,et al.  Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence , 1996, Molecular and cellular biology.

[40]  F. Zindy,et al.  Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest , 1995, Cell.

[41]  A. Balmain,et al.  Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. , 1995, Cancer research.

[42]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Gown,et al.  Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma. , 1995, Cancer research.

[44]  A. Lassar,et al.  Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase , 1995, Science.

[45]  Robert Kay,et al.  Expression cloning of oncogenes by retroviral transfer of cDNA libraries , 1995, Molecular and cellular biology.

[46]  R. DePinho,et al.  Inhibition of ras-induced proliferation and cellular transformation by p16INK4 , 1995, Science.

[47]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[48]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[49]  A. Riggs,et al.  Genomic Sequencing , 2010 .

[50]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[51]  J. McDougall,et al.  Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture. , 1991, The American journal of pathology.

[52]  J. McDougall,et al.  Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[53]  E. Fuchs,et al.  Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various stages of keratinization , 1987, The Journal of cell biology.

[54]  C. Der,et al.  rasH mutants deficient in GTP binding , 1986, Molecular and cellular biology.

[55]  J W Gray,et al.  Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[56]  B. Bernard,et al.  Human epidermis reconstructed by culture: is it "normal"? , 1986, The Journal of investigative dermatology.